IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Hemant Surgical Industries IPO is a book build IPO listing on BSE SME exchange. The company is based in Mumbai and caters to Healthcare sector. Hem Securities is the merchant banker of Hemant Surgical Industries IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th May 2023.
Hemant Surgical Industries IPO posted revenues of Rs 111.50 crores and PAT of Rs 7.65 crores in FY25 on annualised basis.Financial results of Hemant Surgical Industries IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Hemant Surgical Industries IPO PAT Margin is 7.01%, ROCE (Return on Capital Employed) is 37.98% as per latest financial. The below table shows Hemant Surgical Industries IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Hemant Surgical Industries IPO is Rs 93.96 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Hemant Surgical Industries IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Hemant Surgical Industries IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Hemant Surgical Industries IPO is ₹93.96 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Hemant Surgical Industries IPO has a Price-to-Earnings (PE) ratio of 12.28 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Hemant Surgical Industries IPO reported revenue of ₹111.50 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Hemant Surgical Industries IPO provide insights into sales growth, market demand, and business scalability.
Hemant Surgical Industries recorded an EBITDA of ₹ 10.16 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Hemant Surgical Industries Profit After Tax (PAT) is ₹7.65 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 109.14 Cr.
EBITDA Margin:
9.31
%
Net Worth: ₹ 23.59 Cr.
Market Capitalisation:
₹ 93.96 Cr.
P/E:
12.28 times
P/BV: 1.94 times
EV/EBITDA: 9.12 times
Hemant Surgical Industries operates in Healthcare and Provide Medical Equipment's And Disposables. The Issue is listed on BSE SME in Jun, 2023. Hemant Surgical Industries IPO size was 24.84 with Issue price of 90.00 .
Merchant Banker(s) of Hemant Surgical Industries IPO: Hem Securities Limited
Hemant Surgical Industries IPO subscription was 150.59 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Hemant Surgical Industries IPO listed at a listing price of 171.00 against the offer price of 90.00.
The current market price of Hemant Surgical Industries is 105.50.
Why Us?
